Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multicentric Study of Olaparib in PALB2-related Advanced Pancreatic Cancer (PALBOLA)

NCT06078787 is registered in ClinicalTrials.gov with Azienda Ospedaliero-Universitaria di Modena as lead sponsor.

NCT NCT06078787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06078787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multicentric Study of Olaparib in PALB2-related Advanced Pancreatic Cancer (PALBOLA)
Lead sponsor
Azienda Ospedaliero-Universitaria di Modena
Phase
Phase 2
Overall status
Unknown status
Start date
August 1, 2023
Completion date
August 1, 2026
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced pancreatic cancer, metastatic pancreatic cancer